Long non-coding RNAs are a relatively recently discovered class of molecules often referred to as "dark matter" of the human genome. These naturally occuring molecules do not code for proteins but fulfill important regulatory functions in the cell that could be exploited as a new therapeutic approach for multiple indications.

Amaroq's research team has discovered IncRNA molecules that are highly expressed in cancer cells, and once removed, cancer cell growth slows. Amaroq Therapeutics is developing innovative therapeutics to target IncRNAs for cancer treatment.